Abstract
Regulatory T cells participate in several immune responses including autoimmune reactions inducing selftolerance, tumor immunity, transplantation tolerance and microbial infection. Nevertheless, regulatory T cells actions seem to be different when they are in the central nervous system (CNS), since they interact with resident cells of the CNS, according to the particular conditions elicited in this compartment. This review focuses on the role of regulatory T cells in health, autoimmune and other CNS diseases, pointing out their interactions with resident CNS cells.
Keywords: Brain tumor, central nervous system, cerebral vascular diseases, experimental autoimmune encephalomyelitis, multiple sclerosis, neuroinflammation, regulatory T cells, central nervous system (CNS), glucocorticoid-induced TNF receptor (GITR), antigen presenting cells (APC), Tr1 Regulatory Cells, neurodegenerative disorders, antiproliferative action, experimental autoimmune encephalomyelitis (EAE), autoimmune encephalomyelitis, acetylcholine, glutamate, serotonin, vascular disease, microglia activation, brain tumors, glioblastoma multiforme, heme oxygenase-1 (HO-1), neoangiogenesis, cerebral malaria (ECM), Cytotoxic T lymphocyte-associated antigen 4, Glucocorticoid-induced TNF receptor, Major histocompatibility complex class II
Central Nervous System Agents in Medicinal Chemistry
Title: Regulatory T Cells in Central Nervous System: in Health and Disease
Volume: 10 Issue: 4
Author(s): Brenda Saenz, Jesus Perez-H and Anahi Chavarria
Affiliation:
Keywords: Brain tumor, central nervous system, cerebral vascular diseases, experimental autoimmune encephalomyelitis, multiple sclerosis, neuroinflammation, regulatory T cells, central nervous system (CNS), glucocorticoid-induced TNF receptor (GITR), antigen presenting cells (APC), Tr1 Regulatory Cells, neurodegenerative disorders, antiproliferative action, experimental autoimmune encephalomyelitis (EAE), autoimmune encephalomyelitis, acetylcholine, glutamate, serotonin, vascular disease, microglia activation, brain tumors, glioblastoma multiforme, heme oxygenase-1 (HO-1), neoangiogenesis, cerebral malaria (ECM), Cytotoxic T lymphocyte-associated antigen 4, Glucocorticoid-induced TNF receptor, Major histocompatibility complex class II
Abstract: Regulatory T cells participate in several immune responses including autoimmune reactions inducing selftolerance, tumor immunity, transplantation tolerance and microbial infection. Nevertheless, regulatory T cells actions seem to be different when they are in the central nervous system (CNS), since they interact with resident cells of the CNS, according to the particular conditions elicited in this compartment. This review focuses on the role of regulatory T cells in health, autoimmune and other CNS diseases, pointing out their interactions with resident CNS cells.
Export Options
About this article
Cite this article as:
Saenz Brenda, Perez-H Jesus and Chavarria Anahi, Regulatory T Cells in Central Nervous System: in Health and Disease, Central Nervous System Agents in Medicinal Chemistry 2010; 10 (4) . https://dx.doi.org/10.2174/187152410793429674
DOI https://dx.doi.org/10.2174/187152410793429674 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Cytogenetics and Cytogenomics of Brain Diseases
Current Genomics Mast Cells and Basophils: Trojan Horses of Conventional Lin- Stem/Progenitor Cell Isolates
Current Pharmaceutical Design Advances in Helper-Dependent Adenoviral Vector Research
Current Gene Therapy Gold Nanoparticle-Based Drug Delivery Platform for Antineoplastic Chemotherapy
Current Drug Metabolism Recent Progress on Apoptotic Activity of Triazoles
Current Drug Targets Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers
Current Pharmaceutical Design A Mini Review on Interactions Between Neural Stem Cells and Biomaterials
Recent Patents on Regenerative Medicine Analysis of Microarray Gene Expression Data
Current Bioinformatics Thioredoxin, Glutathione and Related Molecules in Tumors of the Nervous System
Current Medicinal Chemistry Subdural Pharmacotherapy for the Treatment of Intractable Focal Neocortical Epilepsy
Drug Delivery Letters Nose to Brain Delivery: New Trends in Amphiphile-Based “Soft” Nanocarriers
Current Pharmaceutical Design Low Concentration of Caffeine Inhibits the Progression of the Hepatocellular Carcinoma <i>via Akt</i> Signaling Pathway
Anti-Cancer Agents in Medicinal Chemistry Flavonoids as Anticancer Agents: Recent Progress and State of the Art?
Current Organic Chemistry Tumor-Targeting Peptides: Ligands for Molecular Imaging and Therapy
Anti-Cancer Agents in Medicinal Chemistry Gene Therapy Approaches for the Selective Killing of Cancer Cells
Current Pharmaceutical Design microRNA, Cancer and Cancer Chemoprevention
Current Molecular Pharmacology Engineered Liposomes for Drug Delivery and Biomedical Imaging
Recent Patents on Nanomedicine Metal Based Frameworks for Drug Delivery Systems
Current Topics in Medicinal Chemistry Cancer Diagnosis and Treatment Guidance: Role of MRI and MRI Probes in the Era of Molecular Imaging
Current Pharmaceutical Biotechnology Tumorspheres Derived from HCC Cells are Enriched with Cancer Stem Cell-like Cells and Present High Chemoresistance Dependent on the Akt Pathway
Anti-Cancer Agents in Medicinal Chemistry